Inactivation of the retinoblastoma (Rb) tumor suppressor protein is essential for the G1/S transition during mammalian cell cycle progression. Although Rb is inactivated by phosphorylation by cyclins D and E and their associated kinases during cell cycle progression, we find that Rb is inactivated upon apoptotic stimulation by Fas through the mediation of p38 kinase, independent of cyclins and cyclin-dependent kinases (cdks). Inactivation by p38 kinase coincided with increased phosphorylation of Rb leading to dissociation of E2F and increased transcriptional activity; such p38-mediated changes in Rb function occurred only during Fas stimulation but not mitogenic progression. p38 kinase targets Rb preferentially and had minimal effects on p107 and had no effect on p130 function. We also find that phosphorylation site mutants of Rb (PSM7LP and PSM9-Rb) that cannot be inactivated by cdks can be targeted by Fas and p38 kinase, suggesting that Rb inactivation by these kinases is biochemically and functionally distinct. It appears that Rb inactivation is achieved by different kinase cascades in response to mitogenic and apoptotic signals.
Introduction
The retinoblastoma (Rb) tumor suppressor protein plays a vital role in regulating the proliferation of normal mammalian cells by maintaining the integrity of the G1/S checkpoint (Weinberg, 1995) . Upon mitogenic stimulation, the cell cycle regulatory machinery allows the precise inactivation of Rb function in the mid-to late G1 phase of the cell cycle facilitating the entry of cells into the S phase. During the course of normal cell cycle progression, Rb is inactivated by sequential phosphorylation events mediated by cyclins D and E and their associated kinases, namely cyclin-dependent kinases (cdk) cdk4/cdk6 in the case of cyclin D and cdk2 in the case of cyclin E (Taya, 1997) . Inactivation of the RB gene by deletion or mutation or a functional inactivation of the Rb protein by viral oncoproteins like HPV E7, adenovirus E1A or SV40 large T-antigen can lead to inappropriate cell proliferation and contribute to oncogenic transformation (Chellappan et al., 1992; Nevins, 1992) .
It is established that the growth suppressive property of Rb is brought about by inhibiting the E2F family of transcription factors (Dyson, 1998; Nevins, 1998) . Rb is known to bind to the transcriptional activation domain of E2Fs 1, 2 and 3 and repress their activity by recruiting histone de-acetylase 1 (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998) . Inactivation of Rb, either genetically or functionally, disrupts its interaction with E2F, leading to increased E2F-mediated transcription. E2F1 is able to induce S-phase entry by itself, since overexpression of E2F1 in quiescent cells in the absence of any other growth stimulants induced cell proliferation (DeGregori et al., 1995) . It has been demonstrated that the expression of a variety of genes necessary for Sphase entry like cyclin E, cyclin A and cdk2 is regulated by E2F family members and their promoters have E2F binding sites (Adams and Kaelin, 1995; Muller and Helin, 2000; Takahashi et al., 2000) . Further, many genes necessary for DNA synthesis are regulated by E2F family proteins: examples include DNA polymerase alpha, thymidylate synthase, thymidine kinase, dihydrofolate reductase, MCM3, CDC6 and ORC1L (Ishida et al., 2001; Muller et al., 2001; Ren et al., 2002) . It is generally accepted that inactivation of Rb at the G1/S boundary by phosphorylation releases transcriptionally active E2F which can induce the cell cycle genes, thus facilitating S-phase entry and cell proliferation (Sherr, 1994; Weinberg, 1995; Harbour and Dean, 2000a, b; Nevins, 2001) .
In addition to cell proliferation, some E2F family members, especially E2F1, can induce apoptosis under certain conditions (Qin et al., 1994; Shan and Lee, 1994; Phillips and Vousden, 2001 ). Overexpression of E2F1 in Rat-1 cells promotes premature S-phase entry and apoptosis. Further, studies on E2F1-null mice also support a role for E2F1 in the apoptotic process (Field et al., 1996) . It has been shown that E2F1 can induce apoptosis in collaboration with p53 (Shan and Lee, 1994; Wu and Levine, 1994) or independent of p53 (Hseih et al., 1997) . The p53-dependent pathway is activated by the transcriptional induction of p14ARF promoter (Bates et al., 1998) ; this protein has been demonstrated to bind to mdm2 and inhibit the proteolytic degradation of p53. The p53-independent pathway is mainly mediated through the p73 protein, whose promoter is a transcriptional target of E2F1 Lissy et al., 2000) . In addition, other apoptosis-related proteins like Apaf1 are transcriptionally induced by E2F1 , contributing to the apoptotic process. It has been suggested that the transcriptional activation domain of E2F1 is not necessary for inducing apoptosis (Hseih et al., 1997) , but the fact that various genes involved in the apoptotic process are induced by E2F1 suggests that the transcriptional activity of E2F1 contributes to the process.
Thus it appears that E2F1 has proliferative and proapoptotic properties, and both can be negated by the Rb protein (Asano et al., 1996; Wang, 1997) . Hence, it may be imagined that signaling pathways that induce proliferation or apoptosis would inactivate Rb elevating E2F-mediated transcription; consistent with this, we had observed that Fas stimulation of Jurkat cells led to Rb inactivation through the mediation of the p38 kinase (Wang et al., 1999) . Here we show that inactivation of Rb upon normal mitogenic progression and Fas stimulation occurs through different mechanisms. Fas stimulation of serum-starved, quiescent cells results in the inactivation of Rb through the p38 kinase independent of cyclins and cdks. We also find that phosphorylation site mutants of the Rb protein that could not be targeted by cdks were effectively inactivated by the p38 kinase. Our results suggest that Rb can be inactivated by different kinases depending on the specific extracellular signal, in each case leading to the disruption of the Rb-E2F complexes resulting in elevated E2F-mediated transcription.
Results

Rb inactivation by p38 kinase is independent of cdk activity
We had demonstrated earlier that the p38 kinase is able to phosphorylate Rb effectively in vitro. Further, cotransfection of p38 kinase could reverse Rb-mediated repression of E2F activity; this required a functional E2F binding site on the promoter (Wang et al., 1999) . This did not exclude the possibility that p38 kinase is inactivating Rb indirectly by inducing cdk activity. To verify this possibility, Rb-negative Saos-2 cells were transiently transfected with an E2CAT reporter whose activity was induced by cotransfecting E2F1. As shown in Figure 1a , cotransfection of p38 kinase could effectively release Rb-mediated repression of E2F1. Cotransfection of an excess of dominant-negative cdk2 or cdk4/6 had no effect on the p38-mediated inactivation of the Rb protein. This suggests that the p38 kinase can inactivate Rb in the absence of cdks known to inactivate Rb. That the kinase activity of p38 was essential for Rb inactivation was demonstrated by using a dominant-negative p38 kinase, which could effectively prevent the wild-type (WT) p38 from inactivating Rb. It has been reported that Fas stimulation can induce p38 kinase (Juo et al., 1997) and hence a similar set of experiments was conducted on Jurkat cells, where p38 kinase was induced by treating the cells with an anti-Fas antibody for 2 h ( Figure 1b) . As we had previously reported, Fas stimulation inactivated Rb protein effectively and induced E2F-mediated transcription (Wang et al., 1999) . The Fas-mediated inactivation of Rb was not affected by ablating cdk2, 4 or 6 using dominantnegative kinases; in contrast, dominant-negative p38 kinase could prevent the Fas-induced inactivation of Rb. This experiment shows that increasing the levels of p38 kinase in cells, either by transfection or by Fas stimulation, can lead to Rb inactivation, independent of cdk activity. This was further verified by repeating the Fas stimulation of Jurkat cells that were rendered quiescent by serum starvation for 24 h to reduce cdk activity; it was found that Fas could efficiently reverse Rb-mediated repression of E2F even in cells rendered quiescent by serum starvation. It was also found that Fas ligand could bring about the inactivation of Rb almost as efficiently as the Fas antibody (Figure 1c) , suggesting that such an event can be brought about by the natural activator of the Fas receptor.
Rb inactivation by serum and Fas occurs through different pathways
Since we found that p38 can inactivate Rb in response to the apoptotic stimulation by Fas, attempts were made to see whether p38 kinase contributes to Rb inactivation mediated by mitogen stimulation as well. The strategy was to transiently transfect Jurkat cells with E2-CAT, E2F1 and Rb, following which they were rendered quiescent by serum starvation. Upon serum stimulation for 16 h, there was a total reversal of Rb-mediated inhibition of E2F activity as expected. As shown in Figure 1d , cotransfection of a combination of dominant-negative cdk4 and cdk6 or dominant-negative cdk2 alone prevented the inactivation of Rb by serum, whereas cotransfection of a dominant-negative p38 construct had no effect. This is in contrast to Fas stimulation, where dominant-negative cdks had no effect on the inactivation of Rb (Figure 1b) , while it was blocked by the dominant-negative p38 kinase. Similar results were obtained when chemical inhibitors of cdks (olomoucine and roscovitine) and p38 kinase (SB203580) were used ( Figure 1e ).
To verify whether the cdk inhibitors are functioning as expected in our experimental system, Jurkat cells were treated with olomoucine or roscovitine under conditions used for the cotransfection experiments in Figure 1e . Immunoprecipitations for cyclin D or E were carried out and the associated kinase activity assessed by an in vitro assay using histone H1 as substrate. As can be seen from Figure 2a , treatment of the cells with olomoucine or roscovitine led to a reduction in the amount of kinase activity associated with the cyclins, showing that cdk activities were indeed blocked in the cotransfection experiments. Similarly, experiments were conducted to verify whether the dominant-negative cdks were indeed inhibiting the cdk activities at the concentrations they were transfected. Jurkat cells were transfected with cyclin D or E alone or with dominant-negative cdk4 and 6 or cdk2. Lysates from untransfected cells or the transfected cells were immunoprecipitated with antibodies to cyclin D or E and the associated kinase activity was determined by an in vitro assay using histone H1 as substrate. As shown in Figure 2b , transfection of cyclin D or E resulted in an increase in the associated kinase activity; but cotransfection of the dominant-negative cdks reduced the kinase activities to Regulation of Rb by cdks and p38 kinase N Nath et al the levels observed in untransfected cells. This experiment shows that both chemical inhibitors and dominant-negative kinases are indeed inhibiting the kinase activities associated with cyclins; thus, Fas is indeed functioning independent of cyclin-cdk activity. The biochemical mechanisms underlying the inactivation processes were then examined. A Western blot analysis of Jurkat cells subjected to serum stimulation or Fas stimulation showed a significant amount of Rb phosphorylation ( Figure 2c) ; whereas SB203580 could prevent the Fas-mediated phosphorylation of Rb, it had no effect on Rb phosphorylation brought about by serum stimulation. Since it has been suggested that Rb can be regulated by other modifications as well, an experiment was designed to examine whether the mobility change observed upon Fas stimulation was indeed due to phosphorylation. Toward this purpose, extracts lacking phosphatase inhibitors were prepared from Fas-stimulated Jurkat cells; the extracts were treated with l-protein phosphatase in vitro and the Rb status was assessed by Western blotting. As shown in Figure 2d , phophatase treatment abolished the Fasinduced change in Rb migration. There was no change in migration when the lysates contained phosphatase inhibitors, NaF and Na 3 VO 4 (data not shown), showing that the inactivation of Rb caused by Fas is due to phosphorylation. The phosphorylation status of the Rb protein was directly reflected in its ability to interact with E2F, as determined by EMSA on Rb immunoprecipitates (Figure 2e) . Stimulation of cells with either serum or Fas could lead to a dissociation of E2F from Rb, but SB203580 could block the dissociation occurring only in response to Fas stimulation. These results suggest that two different classes of kinases mediate the inactivation of Rb in response to mitogenic and apoptotic signals, but both lead to elevated E2F activity.
p38 kinase and Fas preferentially inactivate Rb
It was next examined whether p38 kinase can functionally inactivate Rb family proteins p107 and p130 as well. A cotransfection experiment was performed in Jurkat cells using E2F5 and DP1 to stimulate E2CAT reporter, instead of E2F1. As shown in Figure 3a , cotransfection of p107 or p130 could efficiently repress E2F5-mediated transcriptional activity. Cotransfection of p38 kinase could partially reverse p107-mediated repression of E2F5; in contrast, it had no effect on p130. Under identical conditions, p38 kinase could effectively inactivate Rb, suggesting that the p38 kinase target sites present on the Rb protein are missing in p130.
Additional experiments were designed to evaluate whether Fas also preferentially targets Rb. To verify this, Jurkat cells were transiently transfected with E2F5 and p107 or p130 and subjected to Fas stimulation for 2 h. It was found that Fas stimulation had a modest effect on p107 function ( Figure 3b) ; but this was significantly lower than that observed for Rb protein.
Like overexpression of p38 kinase, Fas stimulation did not reverse p130-mediated inhibition of E2F activity. This is in contrast to serum stimulation, which could effectively reverse both p107-and p130-mediated repression of E2F activity (Figure 3c ). It was further examined whether Fas stimulation dissociated E2F transcription factor from p107 and p130. Whole-cell extracts from control or Fas-treated Jurkat cells were immunoprecipitated with antibodies to p107, p130 and Rb, and the presence of E2F activity in the immunoprecipitate was assessed by an EMSA. As shown in 1-3) or Fas-stimulated Jurkat cells (lanes 4-6) were immunoprecipitated with antibodies to p107, p130 and Rb. EMSA of the immunoprecipitates shows that Fas stimulation leads to a dissociation of E2F from Rb, but not p107 or p130
Regulation of Rb by cdks and p38 kinase N Nath et al Figure 3d , there was a considerable amount of E2F present in association with p107, p130 as well as Rb (lanes 1-3) . Upon Fas stimulation, there was no detectable change in the amounts of E2F associated with p107 and p130 (lanes 4 and 5). In contrast, Fas stimulation led to a total dissociation of E2F from Rb within 2 h (compare lanes 3 and 6). This experiment suggests that Fas stimulation specifically targets Rb and Rb-E2F complexes, and has minimal effects on other Rb family proteins.
Cdks and p38 kinase target different sites on the Rb protein
Attempts were made to assess whether p38 kinase and cdks target the same phosphorylation sites on the Rb protein. The strategy was to compare the inactivation of phosphorylation site mutants (PSM) of Rb Wang, 1996, 1997) by cdks and p38 kinases. These phosphorylation site mutants of Rb have been generated in the context of the full-length Rb protein or only the large pocket (LP) region, and constructs with seven such sites mutated have been found to be resistant to inactivation by cdks and were constitutively active (Knudsen and Wang, 1997) . As shown in Figure 4a , WT full-length Rb protein could repress E2F1 activity very effectively, and this repression could be released by cotransfecting cyclin D or p38 kinase. PSM9I-Rb, which has nine phosphorylation sites mutated, was equally effective in inhibiting E2F function; interestingly, p38 kinase could effectively reverse the transcriptional repression. In contrast, cyclin D was not able to inactivate the PSM9I-Rb and release the transcriptional repression of E2F1. A similar experiment was conducted using WT LP of the Rb protein, or a construct with seven phosphorylation sites mutated (PSM7LP). As shown in Figure 4b , p38 kinase could reverse the transcriptional repression mediated by both WT and PSM7LP, but cyclin D had no effect on the PSM7LP. This result suggests that the p38 kinase and cdks target different sites on the Rb protein.
It was next examined whether the differential effects of p38 kinase and cdks on the PSM mutants of Rb reflected the ability of these constructs to respond to mitogenic or apoptotic signals. As shown in Figure 4c , WT full-length Rb, PSM9I-Rb, WT LP as well as PSM7LP all could repress E2F1-mediated transcription in Saos-2 cells. The transfected cells were subjected to serum starvation, followed by serum stimulation for 16 h. Serum stimulation led to the inactivation of the WT full-length Rb as well as the LP; in contrast, there was no inactivation of the PSM7LP or the PSM9I. This shows that Rb was inactivated by cdks upon mitogenic stimulation, and parallels the effect of cotransfection of cyclin D. In a similar experiment, Saos-2 cells cotransfected with the same constructs were stimulated with an anti-Fas antibody for 2 h ( Figure 4d) ; here it was found that Fas stimulation led to the inactivation of all the four Rb constructs. This result clearly demonstrates that apoptotic stimuli like Fas can target even constitutively active forms of the Rb protein, and such signals target different sites on the Rb protein.
Attempts were made to see whether inactivation of the PSM constructs by p38 kinase or Fas correlated with their phosphorylation. Toward this purpose, Saos-2 cells were cotransfected with E2F1 along with WT LP of Rb or the PSM7LP. Cotransfection of p38 kinase or cyclin D could induce phosphorylation of the WT LP Figure 5a ). In contrast, cyclin D could not induce phosphorylation of the PSM7LP, while the p38 kinase was very effective in this aspect, reflecting the effects of these kinases on Rb-mediated repression of E2F1. We next examined whether there was a differential phosphorylation of the WT and PSM7LP in response to Fas and serum stimulation. As shown in Figure 5b , stimulation of the transfected cells with either Fas or serum led to the phosphorylation of the WT Rb LP; but only Fas stimulation led to the phosphorylation of the PSM7LP. This confirms our finding that Fas and serum target different sites on the Rb protein, and the responses are mediated through p38 kinase and cdks, respectively. The effect of p38 and cyclin D on the Rb-E2F interaction was examined by an immunoprecipitation-EMSA analysis. Whole-cell extracts prepared from Saos-2 cells transfected with E2F1 and WT Rb LP were immunoprecipitated with an anti-Rb antibody, and the presence of E2F in the immunoprecipitate was examined by an EMSA. As shown in Figure 5c , there is a considerable amount of E2F present in association with the transfected Rb (lane 1). When p38 or cyclin D is cotransfected along with WT LP, E2F cannot be detected in the Rb immunoprecipitates, suggesting that the interaction between Rb and E2F is disrupted (lanes 2 and 3). Similarly, E2F is present in an Rb immunoprecipitate of Saos-2 cells transfected with PSM7LP (lane 4). In this case, cotransfection of p38 led to the ablation of E2F from the Rb immunoprecipitate, but there was still a significant amount of E2F bound to PSM7LP when cyclin D was transfected (lanes 5 and 6). This suggests that the phosphorylation of WT and PSM7LP Rb correlates with the dissociation of E2F1 and its transcriptional activity. It was further examined whether the results obtained in the cotransfection experiment reflected the changes occurring when cells respond to Fas or serum. As can be seen from Figure 5d , Fas treatment of the transfected cells led to a dissociation of E2F from both WT and PSM7LP, but serum stimulation could dissociate E2F only from the WT LP, but not PSM7LP. This supports the finding that serum stimulation and Fas treatment can both inactivate the Rb protein, but they target different phosphorylation sites.
Discussion
The tumor suppressor protein Rb and its downstream targets, the E2F family of transcription factors, have been documented to play significant roles in both proliferative and apoptotic pathways (Adams and Kaelin, 1996; Helin, 1998; Muller and Helin, 2000; Phillips and Vousden, 2001) . Although these vital components of the cell cycle machinery have been found to respond to extracellular stimuli leading to proliferation or apoptosis, it is not yet clear how this distinction occurs at the molecular level. The studies we describe here provide novel insights into how Rb and E2F are regulated differentially leading to the disparate end results.
The results presented here lead to four major conclusions. First, we show that p38 kinase-mediated inactivation of Rb is independent of cdk activity. This inactivation of Rb by p38 kinase is physiological, in that it occurs when p38 levels are elevated by overexpression (b) were immunoprecipitated with an anti-Rb antibody and the presence of E2F examined by EMSA. While both p38 and cyclin D can dissociate E2F from WT pocket, only p38 can dissociate it from PSM7LP (c). Similarly, serum stimulation can dissociate E2F only from WT pocket, while Fas stimulation can dissociate E2F from both WT and PSM7LP (d) or induction by Fas. The observation that p38 kinase can inactivate Rb in the presence of dominant-negative cdks or chemical inhibitors of cdk activity indicates that p38 kinase is probably inactivating Rb directly, and not through known regulators of Rb function. This contention is supported by our observation that Rb can be effectively phosphorylated by p38 kinase in vitro (Wang et al., 1999) . We believe that p38 kinase is the first kinase outside the cdk family that can inactivate Rb in a physiologically relevant manner.
The second conclusion to be drawn from this study is that different kinases inactivate Rb depending on the extracellular signal a cell receives. As we demonstrate here, proliferative signals lead to Rb inactivation mainly mediated by cdks, independent of p38 activity; in stark contrast, an apoptotic signal emanating from Fas inactivates Rb mainly through the p38 kinase. This is significant considering that Rb is known to act as a barrier to proliferation as well as apoptosis. The involvement of two distinct signaling cascades in the inactivation of Rb is also reflected in the kinetics of the process as well: whereas Fas stimulation leads to Rb phosphorylation and inactivation within 30 min (Wang et al., 1999) , serum stimulation takes up to 12 h.
Our results suggest that inactivation of Rb can occur by cdk-independent mechanisms in response to specific stimuli, and may contribute to the final biological outcome of the signal. It has been reported that Fas stimulation leads to a caspase-mediated cleavage of Rb (Chen et al., 1997; Dou et al., 1997) , which essentially inactivates it. An Rb molecule with the caspase site mutated could confer resistance to TNFa-mediated, but not Fas-mediated apoptosis in Rb-negative cells (Tan et al., 1997; Tan and Wang, 1998) . Our findings may imply that Rb inactivation by p38-mediated phosphorylation may be an alternate way of achieving Rb inactivation. As to the reason why Rb has to be inactivated upon apoptotic stimuli, it has been postulated that Rb inactivation may be a necessary step for apoptosis to occur, since Rb has antiapoptotic properties (Wang, 1997; Tan and Wang, 1998) . This would complement the fact that E2F1, the major target of Rb, can induce apoptosis in collaboration with p53 (Shan and Lee, 1994; Wu and Levine, 1994) .
The third point that can be made is in regard to the preferential inactivation of Rb by the p38 kinase compared to p107 and p130. Although there is a minimal inactivation of p107 by p38 kinase, it is not as significant as that of Rb inactivation. Neither cotransfection nor induction of p38 by Fas had any effect on p130, and there was no reversal of repression of E2F5. Interestingly, all the three pocket proteins are inactivated by serum stimulation: the difference is only in the response to Fas. This might indicate that inactivation of Rb might facilitate both apoptotic and proliferative processes, whereas p107 or p130 might modulate only proliferation. Although a definite role for the Rb protein in attenuating apoptosis has been demonstrated, no such data exist for p107 and p130 proteins. Further, it has been demonstrated that the capacity to induce apoptosis is limited to E2F1 (DeGregori et al., 1997), whereas E2Fs 4 and 5 were incapable of inducing apoptosis. Hence it may be envisaged that inactivation of p107 and p130, which mainly repress E2Fs 4 and 5, may not facilitate the apoptotic process. The use of a Fas-induced kinase that can phosphorylate Rb preferentially would thus lead to E2F1 activation facilitating the apoptotic process. It has been postulated that E2F1 may be promoting apoptosis by helping the induction of downstream caspases (Hou et al., 2000; Yang et al., 2000; Muller et al., 2001) ; the immediate induction of E2F activity upon Fas stimulation may support this possibility.
Finally, the data provide evidence for biochemical differences in the inactivation of Rb by cdks and p38. As we clearly demonstrate, PSM7LP and PSM9I-Rb can be inactivated by p38, but are not affected by cdks. This shows that the sites on the Rb protein that are targeted by cdks and p38 kinases are different. It has been speculated that phosphorylation of Rb may affect the interaction between the A and B pockets, probably affecting the integrity of the domain (Lee et al., 1998 ). It appears that p38-mediated phosphorylation has similar effects, since it disrupts the binding of E2F to Rb (Wang et al., 1999) . Studies by the Dean lab (Harbour et al., 1999) have demonstrated that cyclin E/cdk2-mediated phosphorylation is required for the dissociation of E2F1 from Rb; based on this finding, it may be concluded that p38-mediated phosphorylation is functionally similar to the inactivation of Rb by cyclin E/cdk2.
We believe that these results reveal the dichotomy of Rb-regulatory pathways generated in response to different extracellular signals and further studies in this direction will shed light on the precise mechanisms governing the switch between apoptosis and proliferation.
Materials and methods
Transfections
Jurkat cells were electroporated using a Bio-Rad Gene Pulser and Saos-2 osteosarcoma cells were transfected by calcium phosphate precipitation method. Cells were harvested after 72 h and assays for CAT and b-galactosidase were performed using standard protocols, and typical results from multiple (2-3) experiments are shown. A pSV-b gal vector (2 mg) was included in all transient transfections as an internal control. Constructs pDCE2F1, pE2CAT and pSVRb are described in Wang et al. (1999) . The expression vectors for PSM LP domain and full-length Rb used in this study are PSM7LP (S780A, S788D, S795A, S807A, S811L, T821A, T826A) and PSM9I-Rb (S608A and S612A, in addition to the sites mutated in PSM7LP) along with the WT LP (pCMV.WTLP) as described (Knudsen and Wang, 1997) . Other expression vectors used in this study are pSRap38, pRC/CMVCycD1, pCMVcdk2D145N (dominant-negative cdk2), pCMVcdk4DN and pCMVcdk6DN. The dominant-negative p38 construct was a kind gift of Dr JiaHuai Han, Scripps Research Institute, La Jolla, CA, USA. Plasmids (2 mg) were used in all transfections unless mentioned otherwise. In all, 4 mg dominant-negative constructs was used while 4 mg of pDCE2F5 along with 2 mg of DP1 was used in the studies with p107 and p130.
Cell treatments
For serum stimulation experiments, cells were transferred to medium without serum 12-15 h after transfection. After 36 h, cells were stimulated with medium containing 15% fetal bovine serum for 16 h. A measure of 1 mg of Rb was used to repress E2F1 activity in serum stimulation experiments. Fas stimulation was conducted by adding 50 ng/ml of agonistic anti-Fas antibody (MBL) to the transfected cells 2 h before harvesting. Fas ligand (100 ng/ml) was used in a similar experiment on transfected Jurkat cells. The kinase inhibitors were added at the time of Fas or serum stimulation at the following concentrations: p38 inhibitor SB203580, 10 mm; cdk inhibitors olomoucine, 200 mm, and roscovitine, 50 mm.
Whole-cell extracts, Western blots and EMSA
Whole-cell extracts prepared by hypotonic shock (Chellappan et al., 1991) were used for Western blots and immunoprecipitations and EMSAs. For detecting the LP proteins, anti-Rb polyclonal antibody (C-15, Santa Cruz Biotechnologies) was used, while an anti-Rb monoclonal antibody from Oncogene Science-Calbiochem was used in other experiments. The p107 antibody and p130 antibodies were obtained from Santa Cruz Biotechnologies. Typically, 100-150 mg of whole-cell extracts was used for Western blot experiments. After semidry transfer to supported nitrocellulose membrane, the proteins were detected using an ECL system from Amersham. Phosphatase treatment was carried out in vitro on 75 mg of lysate using 200 U of l-phosphatase at 301C for 30 min, in a buffer containing 50 mm Tris, pH 7.5, 0.1 mm EDTA, 5 mm DTT and 2 mm MnCl 2 . For immunoprecipitations, 50-200 mg of wholecell extracts was treated with 5 ml of the appropriate primary antibody in a volume of 100 ml at 41C for 1 h. In all, 3 mg of Protein A-Sepharose or Protein G-Sepharose in 100 ml volume was then added and incubated for an additional 1 h. The binding was performed in a buffer containing 20 mm HEPES, pH 7.9, 40 mm KCl, 1 mm MgCl 2 , 0.1 mm EGTA, 0.1 mm EDTA, 0.1 mm DTT, 0.1 mm NaF, 0.1 mm Na 3 VO 4 , 0.5% NP40 and 3 mg/ml BSA. The beads were washed six times, boiled in 20 ml of SDS sample buffer and then proteins were separated on 8 or 10% polyacrylamide gels. Kinase assays following immunoprecipitations were performed as described earlier using 4 mg of histone H1 as substrate . EMSA for E2F after immunoprecipitation with Rb, p107 or p130 antibody was performed as described .
